Related Experiment Video
Updated: Aug 15, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Update on diagnosis, management, and prevention of hepatitis B virus infection
1Office of the Director, National Centers for Infectious Diseases, Centers for Disease Control and Prevention, U.S. Naval Medical Research Unit no. 3, Cairo, Egypt.MahoneyF@namru3.navy.mil
Insights
Hepatitis B vaccination programs are successfully reducing chronic hepatitis B virus (HBV) infection rates and liver cancer incidence in children globally. Widespread vaccination is a key strategy for preventing liver disease and its fatal outcomes.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Hepatitis B virus (HBV) infection is a major global cause of liver disease, leading to approximately 1 million deaths annually.
- An estimated 350 million people worldwide are chronically infected with HBV.
- Recent advancements have improved understanding of HBV molecular virology and pathogenesis, alongside developing effective treatments.
Purpose of the Study:
- To highlight the global significance of HBV infection as a cause of liver disease.
- To emphasize the progress in understanding HBV and its treatment.
- To underscore the importance of HBV prevention through vaccination.
Main Methods:
- Review of global HBV infection prevalence and mortality data.
- Analysis of the impact of hepatitis B vaccine introduction into national immunization programs.
- Examination of reported reductions in chronic HBV infection and liver cancer incidence in vaccinated populations.
Main Results:
- Significant reductions in chronic HBV infection prevalence among children have been observed in countries with widespread vaccination.
- The hepatitis B vaccine was recommended for integration into national immunization programs by 1997.
- Taiwanese reports show decreased liver cancer incidence in children due to vaccination programs.
Conclusions:
- Hepatitis B vaccination is a highly effective strategy for preventing chronic HBV infection and reducing liver cancer.
- Global integration of hepatitis B vaccine into infant immunization schedules is crucial for public health.
- Continued efforts in HBV prevention are essential to combat liver disease worldwide.
Abstract:
Acute and chronic hepatitis B virus (HBV) infection is a leading cause of liver disease worldwide. It is estimated that approximately 350 million people worldwide have chronic HBV infection and that 1 million persons die each year from HBV-related chronic liver disease. In the past decade, significant progress in the understanding of the molecular virology and pathogenesis of HBV infection has been made. In addition, effective treatment modalities have been developed for persons with chronic infection. Worldwide, prevention of HBV transmission has become a high priority. In 1992, the Global Advisory Group to the World Health Organization recommended that all countries integrate hepatitis B vaccine into national immunization programs by 1997. Currently, 80 countries have done so and several others are planning to. Many countries have reported dramatic reductions in the prevalence of chronic HBV infection among children born since the hepatitis B vaccine was introduced into infant immunization schedules. Recent reports from Taiwan indicate a reduction in the incidence of liver cancer among children as a result of widespread hepatitis B vaccination programs.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Smallpox
Hepatitis
Viral Hepatitis I: Introduction

